4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-039770
Director bought 2,000 shares at $19.50 ($39,000)
- Director acquired 4,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DOBMEIER ERIC Director | 2019-06-27 | Purchase | +2,000 | $19.50 | $39,000 | 16,000 | D |
| DOBMEIER ERIC Director | 2019-06-27 | Grant or award | +4,000 | 20,000 | D | ||
| Derivatives | |||||||
| DOBMEIER ERIC Director | 2019-06-27 | Grant or award · Non-Qualified Stock Option (Right to Buy) | +13,000 | 13,000 | D | ||
| Open-market purchases · 2,000 sh · avg $19.50 · $39,000 | |||||||
Loading xslF345X03/doc4.xml…